Clintabs Tablet
Clintabs is an FDA-approved preparation containing Clintabs, for veterinary use. Available by prescription.
Clintabs® is a commercial brand of clindamycin hydrochloride, a lincosamide antibiotic utilized extensively in veterinary medicine for the management of specific bacterial challenges. It is a prescription medication available in tablet form for use in dogs, frequently considered by veterinarians for its activity against gram-positive aerobic and anaerobic organisms. At a pharmacological level, the active ingredient clindamycin acts by inhibiting protein synthesis in susceptible bacteria. It binds to the 50S ribosomal subunit, which help address the formation of peptide bonds and may be considered in the context of the bacteria concerns producing the proteins they need to replicate. Clindamycin is characterized by its ability to penetrate many body tissues, including bone, which makes it a frequent point of discussion for managing deep-seated infectious processes. Your veterinarian will determine the clinical appropriateness of Clintabs® based on diagnostic findings such as culture and sensitivity results or specific tissue involvement.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects following the administration of Clintabs® include localized digestive changes such as vomiting, diarrhea or a temporary decrease in appetite. In some cases, owners have observed bloody stools or behavioral shifts including lethargy. While lincosamides are generally well-tolerated, hypersensitivity reactions can occur. Owners should monitor their pet for any unusual changes in bowel habits or persistent digestive distress and contact their veterinarian promptly with any concerns regarding their pet's response to the medication. This medication is typically used with extra caution or avoided in patients with known severe hepatic or renal impairment, as these organs are involved in the metabolism and excretion of the active ingredient. It is also carefully evaluated in pets with a history of gastrointestinal sensitivities. Significant interactions can occur if clindamycin is administered concurrently with neuromuscular blocking agents or certain other antibiotics that may interfere with its mechanism. Your veterinarian is the right person to provide guidance on the necessary duration of use and the most commonly considered monitoring schedule to ensure the management approach remains suitable for your pet's recovery.
Yes. Clintabs is a prescription antibiotic and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home.
Clintabs is a commercial tablet formulation. If your veterinarian determines that a customized strength or a different flavored dosage form—such as a flavored oral liquid or chewable may be considered for—is better suited for your pet, Mixlab can compound the active ingredient (clindamycin) into a customized formulation. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians most commonly discuss Clintabs for the management of bacterial infections involving the mouth, teeth, skin and bones. It is particularly valued for its ability to reach commonly considered levels in bone tissue and for its activity against anaerobic bacteria.
Veterinarians often recommend administering Clintabs with a meal to manage the risk of localized digestive upset. Giving the tablet with food can help ensure it is well-tolerated by your pet's stomach during the management course.
